GlassScriptPhysician profile
Tracy W Winward
NPI 1922008846
$822.03
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.58 · 2020: $67.32 · 2021: $214 · 2022: $124 · 2023: $124 · 2024: $135 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.99 | 2019-2024 | Orilissa |
| Ethicon US, LLC | $138.29 | 2022-2025 | Vistaseal, Dermabond Prineo, Stratafix |
| Hologic Sales and Service, LLC | $77.80 | 2021-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $51.56 | 2020-2022 | |
| Biogen, INC. | $47.48 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $40.13 | 2020-2023 | Injectafer |
| Exeltis, USA INC. | $39.23 | 2021-2022 | |
| Becton, Dickinson and Company | $37.85 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $32.20 | 2023 | |
| Evofem Biosciences, INC. | $24.37 | 2021 | |
| Organon LLC | $24.25 | 2023-2024 | Nexplanon |
| Coloplast Corp | $24.04 | 2023 | Altis |
| Genmab U.S., INC. | $19.85 | 2023 | Tivdak |
| Therapeuticsmd, INC. | $15.48 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $14.75 | 2024 | Bd Onclarity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $13.83 | 2025 | Fibryga |
| Biohaven Pharmaceuticals, INC. | $13.20 | 2021 | |
| Trevena, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Winward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.